Virtual screening of epalrestat mimicking selective ALR2 inhibitors from natural product database: auto pharmacophore, ADMET prediction and molecular dynamics approach

醛糖还原酶 虚拟筛选 药效团 醛糖还原酶抑制剂 醛还原酶 化学 天然产物 立体化学 生物化学
作者
Shalki Choudhary,Om Silakari
出处
期刊:Journal of Biomolecular Structure & Dynamics [Taylor & Francis]
卷期号:40 (13): 6052-6070 被引量:1
标识
DOI:10.1080/07391102.2021.1875878
摘要

Epalrestat is the only effective aldose reductase (ALR2) inhibitor available in the market for the treatment of diabetic neuropathy. Clinical effectiveness of epalrestat in diabetic neuropathy encouraged us to develop some more ALR2 inhibitors with a better therapeutic profile. Herein, we utilized the pharmacophoric features of epalrestat to search some novel ALR2 inhibitors from an InterBioScreen database of natural compounds. ADME and PAINS filters were applied to provide drug-likeness and to remove toxicophores from the screened hits. The pharmacophoric features of 4-hydroxy-2-nonenal (HNE), a well-known substrate of ALR1, were also explored to identify selective ALR2 inhibitors. The structure-based analysis was then adopted to find out the molecules showing interactions with ALR2 which are crucial for their therapeutic activity. These interaction patterns and binding modes were compared with that of epalrestat. Molecular dynamics (MD) analysis was also carried out to get more insight into the interactions of screened hits in the catalytic domain of ALR2. Additionally, the top hits were docked and simulated with aldehyde reductase (ALR1) to determine their selectivity for ALR2 over ALR1. Overall, five hits including STOCKIN-44771, STOCKIN-46041, STOCKIN-59369, STOCKIN-69620 and STOCKIN-88220 were found to possess a good therapeutic profile in terms of key interactions, binding energies and drug-likeness. Two hits, STOCKIN-46041 and STOCKIN-59369, were identified as the most selective ALR2 inhibitors when assessed their selectivity profile.Communicated by Ramaswamy H. Sarma.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
huangJP发布了新的文献求助10
刚刚
野性的曼香完成签到,获得积分10
刚刚
kkkkkkkkk完成签到,获得积分10
刚刚
悦耳睿渊完成签到,获得积分10
1秒前
单身的溪流完成签到 ,获得积分10
1秒前
王二哈完成签到,获得积分10
1秒前
Ing完成签到,获得积分10
1秒前
周少完成签到,获得积分10
2秒前
Coral完成签到,获得积分10
2秒前
susan发布了新的文献求助10
2秒前
山月鹿完成签到,获得积分10
3秒前
xujy完成签到,获得积分10
3秒前
菜虫虫完成签到,获得积分10
3秒前
4秒前
情怀应助小年滚球球采纳,获得10
4秒前
妍宝贝完成签到 ,获得积分10
5秒前
Yurrrrt完成签到,获得积分10
5秒前
5秒前
xinxinqi完成签到 ,获得积分10
5秒前
Jiang完成签到,获得积分10
5秒前
ling361完成签到,获得积分10
6秒前
年轻的路人完成签到,获得积分10
6秒前
东西南北完成签到,获得积分10
6秒前
biosep完成签到,获得积分10
6秒前
安诺完成签到,获得积分10
7秒前
8秒前
刘坦苇完成签到,获得积分10
9秒前
草影花飘完成签到,获得积分10
9秒前
自信的冬日完成签到,获得积分10
9秒前
hdbys发布了新的文献求助10
9秒前
默默的立辉完成签到,获得积分10
9秒前
科研潜水完成签到 ,获得积分10
9秒前
meng完成签到,获得积分10
9秒前
傲娇颖完成签到,获得积分10
10秒前
支妙完成签到,获得积分10
11秒前
852应助勾陈一采纳,获得10
11秒前
Richard完成签到,获得积分10
12秒前
在水一方应助jingdaitianxiang采纳,获得10
12秒前
喻紫寒完成签到 ,获得积分10
12秒前
与其会意完成签到,获得积分10
12秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Immigrant Incorporation in East Asian Democracies 600
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3968719
求助须知:如何正确求助?哪些是违规求助? 3513608
关于积分的说明 11168681
捐赠科研通 3248960
什么是DOI,文献DOI怎么找? 1794573
邀请新用户注册赠送积分活动 875194
科研通“疑难数据库(出版商)”最低求助积分说明 804716